STOCKHOLDERS’ DEFICIT (Details Narrative) - $ / shares	6 Months Ended	12 Months Ended
	Oct. 31, 2023	Apr. 30, 2023	Jun. 30, 2023	May 01, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000
Preferred Stock, Shares Authorized	100	100		100
Preferred Stock, Shares Issued	51	51
Preferred Stock, Shares Outstanding	51	51
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number	6,894,666	7,177,333
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 0.17	$ 0.17
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 9 months	2 years 3 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value	$ 0.11	$ 0.11
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations	282,667